Arthur Bertelsen,Jacques Fellay,Dongliang Ge,David B. Goldstein,John G. McHutchison,Ping Qiu,Kevin Shianna,Jason S. Simon,Alexander J. Thompson,Thomas Urban
申请号:
US13905987
公开号:
US20130251677A1
申请日:
2013.05.30
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The present invention provides genetic markers on human chromosome 19 that are associated with a beneficial response to interferon alpha (IFN-α). These IFN-α response markers are useful, inter alia, to identify patients who are most likely to benefit from treatment with IFN-α pharmaceutical compositions and drug products, in methods of treating patients having a disease susceptible to treatment with an IFN-α, and in methods for selecting the most appropriate therapy for such patients.